TLV: CBI Company Description
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing.
It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies.
The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in.
It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies.
Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional offices in Boston, Massachusetts and Cambridge, Massachusetts.
It operates as a former subsidiary of Clal Industries and Investments Ltd.
Country | Israel |
Founded | 1998 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Avraham Fischer |
Contact Details
Address: Azrieli Center Tel Aviv, 67023 Israel | |
Phone | 972 3 612 1616 |
Website | cbi.co.il |
Stock Details
Ticker Symbol | CBI |
Exchange | Tel Aviv Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | ILS |
ISIN Number | IL0011042806 |
SIC Code | 6799 |
Key Executives
Name | Position |
---|---|
Dr. Avraham Matityahu Fischer M.D. | Chairman and Chief Executive Officer |
Liat Nissan | Chief Financial Officer |
Iris Sadeh | Accountant |
Shiran Manor | General Counsel and Corporate Secretary |
Etty Kliger | Vice President of Research and Development - MediWound |
Dr. Lior Rosenberg M.D. | Vice President of Medical Technologies - MediWound |
Dr. Arnon Aharon M.D. | Medical Director |